Neurotez signs contract with Paragon Bioservices

Neurotez has developed two Leptin products for the treatment of Alzheimer’s disease and other cognitive disorders for which the contract aims at manufacturing of one of the product.

Paragon Bioservices is a contract research and manufacturing organization (CMO) that provides a comprehensive portfolio of services including process development, GMP manufacturing and cell banking.

Paragon’s focus is to bridge the translational divide, to enable protein and cell-based therapeutics into clinical trials.

Neurotez currently uses biochemical, molecular & cell biology and in vivo models to screen, identify and characterize suitable candidate biopharmaceuticals targeting major central nervous system (CNS) disorders with unmet medical need.

Neurotez aims to build a CNS biotechnology company with a fully-integrated platform that spans activities from discovery efforts to proof of concept clinical trials.